# Prevention of Atrial Fibrillation by Low-dose Landiolol Administration After Cardiac Surgery

> **NCT04607122** · PHASE3 · COMPLETED · sponsor: **CMC Ambroise Paré** · enrollment: 400 (actual)

## Conditions studied

- Atrial Fibrillation
- Cardiac Surgery

## Interventions

- **DRUG:** Landiolol
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT04607122
- **Lead sponsor:** CMC Ambroise Paré
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-27
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-07-22
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04607122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04607122, "Prevention of Atrial Fibrillation by Low-dose Landiolol Administration After Cardiac Surgery". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04607122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*